Suppr超能文献

壳聚糖纳米粒作为黑鲷口服 DNA 疫苗载体用于抗副溶血弧菌感染的研究

Potential use of chitosan nanoparticles for oral delivery of DNA vaccine in black seabream Acanthopagrus schlegelii Bleeker to protect from Vibrio parahaemolyticus.

机构信息

College of Life Sciences, Shenzhen Key Laboratory of Marine Biological Resources and Ecological Environment, Shenzhen University, Shenzhen, Guangdong Province, China.

出版信息

J Fish Dis. 2013 Dec;36(12):987-95. doi: 10.1111/jfd.12032. Epub 2013 Sep 30.

Abstract

To develop an effective and easy-to-administer vaccine against vibriosis of fish, the chitosan nanoparticles-loaded DNA vaccine against Vibrio parahaemolyticus was studied. A DNA vaccine was constructed using the outer membrane protein K (ompK) gene of V. parahaemolyticus strain (OS4) and pEGFP-N2 , a eukaryotic expression vector, and the construct was named pEGFP-N2 -OMPK (pDNA). The pDNA was encapsulated in chitosan particles (chitosan/pDNA). The effective diameter, mean diameter and polydispersity of the particles were 284.4 nm, 218.9 nm and 0.160, respectively. Scanning electron microscopy showed that the particles are dispersed as individual nanoparticles with spherical shape of around 200 nm and are homogeneously distributed. Encapsulation efficiency and loading percentage of nanoparticles were 91.5% and 2.08%, respectively. Reverse transcription-polymerase chain reaction (RT-PCR) showed that RNA-containing information of the ompK gene existed in mid-intestine, liver, kidney and muscle 3 weeks after oral administration in black seabream Acanthopagrus schlegelii Bleeker. Expression of the reporter gene, green fluorescent protein (GFP), was observed in the above-mentioned tissues by fluorescence microscopy. Expression of the ompK gene within 3 weeks evoked an immune response. Black seabream was protected from V. parahaemolyticus (OS4), with 72.3% relative percentage survival (RPS) 3 weeks post-vaccination with chitosan/pDNA. The direct agglutination test indicated that oral administration with chitosan/pDNA induced an antibody immune response in fish against V. parahaemolyticus (OS4). Data obtained, here and in other related studies, suggest that chitosan nanoparticles are promising carriers for an oral pDNA vaccine.

摘要

为了开发一种针对鱼类弧菌病的有效且易于管理的疫苗,研究了负载壳聚糖纳米颗粒的副溶血弧菌 DNA 疫苗。使用副溶血弧菌(OS4)菌株的外膜蛋白 K(ompK)基因和真核表达载体 pEGFP-N2 构建了 DNA 疫苗,该构建体命名为 pEGFP-N2-OMPK(pDNA)。pDNA 被包裹在壳聚糖颗粒(壳聚糖/pDNA)中。颗粒的有效直径、平均直径和多分散性分别为 284.4nm、218.9nm 和 0.160。扫描电子显微镜显示,颗粒呈分散状态,为单个纳米颗粒,形状为 200nm 左右的球形,分布均匀。纳米颗粒的包封效率和载药量分别为 91.5%和 2.08%。逆转录聚合酶链反应(RT-PCR)显示,黑鲷口服给药 3 周后,在中肠、肝、肾和肌肉中存在含有 ompK 基因信息的 RNA。通过荧光显微镜观察到报告基因绿色荧光蛋白(GFP)在上述组织中的表达。3 周内 ompK 基因的表达引发了免疫反应。口服壳聚糖/pDNA 可使黑鲷对副溶血弧菌(OS4)产生 72.3%的相对保护率(RPS),3 周后。直接凝集试验表明,口服壳聚糖/pDNA 可诱导鱼类对副溶血弧菌(OS4)产生抗体免疫反应。本研究和其他相关研究的数据表明,壳聚糖纳米颗粒是口服 pDNA 疫苗的有前途的载体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验